Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

James Falko to Humans

This is a "connection" page, showing publications James Falko has written about Humans.

 
Connection Strength
 
 
 
0.159
 
  1. Falko JM. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Endocr Pract. 2018 08; 24(8):756-763.
    View in: PubMed
    Score: 0.017
  2. Allian-Sauer MU, Falko JM. New treatments on the horizon for familial hypercholesterolemia. Expert Rev Cardiovasc Ther. 2012 Oct; 10(10):1227-37.
    View in: PubMed
    Score: 0.011
  3. Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Physician. 2005 Jun 01; 71(11):2123-8.
    View in: PubMed
    Score: 0.007
  4. Aring AM, Jones DE, Falko JM. Information from your family doctor. Diabetic neuropathy. Am Fam Physician. 2005 Jun 01; 71(11):2129-30.
    View in: PubMed
    Score: 0.007
  5. Falko JM, Moser RJ, Meis SB, Caulin-Glaser T. Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia. Curr Diabetes Rev. 2005 May; 1(2):127-35.
    View in: PubMed
    Score: 0.007
  6. Barker BJ, Goodenough RR, Falko JM. Fenofibrate monotherapy induced rhabdomyolysis. Diabetes Care. 2003 Aug; 26(8):2482-3.
    View in: PubMed
    Score: 0.006
  7. Cottrell DA, Marshall BJ, Falko JM. Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome. Curr Opin Cardiol. 2003 Jul; 18(4):301-8.
    View in: PubMed
    Score: 0.006
  8. Cirillo RL, Pozderac RV, Caniano DA, Falko JM. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule. Clin Nucl Med. 1998 Jun; 23(6):345-9.
    View in: PubMed
    Score: 0.004
  9. Sundaram V, Hanna AN, Koneru L, Newman HA, Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. J Clin Endocrinol Metab. 1997 Oct; 82(10):3421-4.
    View in: PubMed
    Score: 0.004
  10. Glueck CJ, Streicher P, Wang P, Sprecher D, Falko JM. Treatment of severe familial hypertriglyceridemia during pregnancy with very-low-fat diet and n-3 fatty acids. Nutrition. 1996 Mar; 12(3):202-5.
    View in: PubMed
    Score: 0.004
  11. Matney K, Berg M, Falko JM, Draper NL. The role of lipoprotein(a) in clotting reactions during lipoprotein apheresis--A case report. J Clin Lipidol. 2016 Mar-Apr; 10(2):438-42.
    View in: PubMed
    Score: 0.004
  12. Cottrell DA, Bello FA, Falko JM. 17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronism. Am J Med Sci. 1990 Dec; 300(6):380-2.
    View in: PubMed
    Score: 0.003
  13. Chevinsky AH, Minton JP, Falko JM. Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg. 1990 Jul; 125(7):935-8.
    View in: PubMed
    Score: 0.002
  14. Snow R, Ruane J, LaLonde M, Shaffer L, Kim B, Graffagnino C, Falko J, Spencer K, Caulin-Glaser T. Randomized trial assessing the impact of a musculoskeletal intervention for pain before participating in a weight management program. J Cardiopulm Rehabil Prev. 2010 May-Jun; 30(3):173-80.
    View in: PubMed
    Score: 0.002
  15. La Londe MA, Graffagnino CL, Falko JM, Snow RJ, Spencer K, Caulin-Glaser T. Effect of a weight management program on the determinants and prevalence of metabolic syndrome. Obesity (Silver Spring). 2008 Mar; 16(3):637-42.
    View in: PubMed
    Score: 0.002
  16. Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7.
    View in: PubMed
    Score: 0.002
  17. Trapnell BC, Mavko LE, Birskovich LM, Falko JM. Metoclopramide suppositories in the treatment of diabetic gastroparesis. Arch Intern Med. 1986 Nov; 146(11):2278-9.
    View in: PubMed
    Score: 0.002
  18. Meis SB, Snow R, Lalonde M, Falko J, Caulin-Glaser T. A systematic approach to improve lipids in coronary artery disease patients participating in a cardiac rehabilitation program. J Cardiopulm Rehabil. 2006 Nov-Dec; 26(6):355-60; quiz 361-2.
    View in: PubMed
    Score: 0.002
  19. Osei K, Holland G, Falko JM. Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients. Arch Intern Med. 1986 Oct; 146(10):1973-7.
    View in: PubMed
    Score: 0.002
  20. Osei K, Weber PA, Falko JM. Coexistence of diabetes mellitus, optic atrophy, and sensorineural deafness: case report. Ann Ophthalmol. 1986 May; 18(5):196-8.
    View in: PubMed
    Score: 0.002
  21. Feher MD, Falko JM. Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. Br Med J (Clin Res Ed). 1986 Mar 01; 292(6520):623.
    View in: PubMed
    Score: 0.002
  22. Osei K, Falko JM. Chronic hyponatremia associated with diabetic amyotrophy. Arch Intern Med. 1986 Mar; 146(3):534-6.
    View in: PubMed
    Score: 0.002
  23. Graffagnino CL, Falko JM, La Londe M, Schaumburg J, Hyek MF, Shaffer LE, Snow R, Caulin-Glaser T. Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors. Obesity (Silver Spring). 2006 Feb; 14(2):280-8.
    View in: PubMed
    Score: 0.002
  24. Hindman L, Falko JM, LaLonde M, Snow R, Caulin-Glaser T. Clinical profile and outcomes of diabetic and nondiabetic patients in cardiac rehabilitation. Am Heart J. 2005 Nov; 150(5):1046-51.
    View in: PubMed
    Score: 0.002
  25. Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R. Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil. 2005 Nov-Dec; 25(6):332-6; quiz 337-8.
    View in: PubMed
    Score: 0.002
  26. Falko JM, Osei K. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med. 1985 Sep 20; 79(3B):92-101.
    View in: PubMed
    Score: 0.002
  27. Snow R, LaLonde M, Hindman L, Falko J, Caulin-Glaser T. Independent effect of cardiac rehabilitation on lipids in coronary artery disease. J Cardiopulm Rehabil. 2005 Sep-Oct; 25(5):257-61; quiz 262-3.
    View in: PubMed
    Score: 0.002
  28. Osei K, Falko JM. Serum C-peptide levels determine glycemic responses in type II diabetic patients treated with combined insulin and sulfonylurea agent. Am J Med Sci. 1985 Apr; 289(4):148-53.
    View in: PubMed
    Score: 0.002
  29. Rudy DR, Falko JM. Osteoporosis in primary care. Ohio State Med J. 1985 Mar; 81(3):208-12.
    View in: PubMed
    Score: 0.002
  30. Osei K, Falko JM. Clinical features, diagnosis and management of insulinoma in 16 consecutive patients: cost-ineffectiveness of non-invasive imaging modalities. Ohio State Med J. 1984 Dec; 80(12):864-9.
    View in: PubMed
    Score: 0.002
  31. Osei K, O'Dorisio TM, Falko JM. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. Am J Med. 1984 Dec; 77(6):1002-9.
    View in: PubMed
    Score: 0.002
  32. Osei K, Kramer DS, Malarkey WB, Falko JM. Pregnancy complicated by insulinoma. Am J Med Sci. 1984 Oct; 288(3):133-5.
    View in: PubMed
    Score: 0.002
  33. Bossetti BM, Kocher LM, Moranz JF, Falko JM. The effects of physiologic amounts of simple sugars on lipoprotein, glucose, and insulin levels in normal subjects. Diabetes Care. 1984 Jul-Aug; 7(4):309-12.
    View in: PubMed
    Score: 0.002
  34. Falko JM, Maeder MC, Conway C, Mazzaferri EL, Skillman TG. Primary hyperparathyroidism: analysis of 220 patients with special emphasis on familial hypocalciuric hypercalcemia. Heart Lung. 1984 Mar; 13(2):124-31.
    View in: PubMed
    Score: 0.002
  35. Falko JM, Reynolds JC, O'Dorisio TM, Bossetti B, Cataland S. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose. Diabetes Care. 1982 Jul-Aug; 5(4):379-85.
    View in: PubMed
    Score: 0.001
  36. Falko JM, O'Dorisio TM, Cataland S. Spurious elevations in glycosylated hemoglobin (HbA1) secondary to hypertriglyceridemia. Arch Intern Med. 1982 Jul; 142(7):1370-1.
    View in: PubMed
    Score: 0.001
  37. Hawley PC, Falko JM. "Pseudo" renal failure after isopropyl alcohol intoxication. South Med J. 1982 May; 75(5):630-1.
    View in: PubMed
    Score: 0.001
  38. Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9.
    View in: PubMed
    Score: 0.001
  39. Zull DN, Falko JM. Metrizamide cisternography in the investigation of the empty sella syndrome. Arch Intern Med. 1981 Mar; 141(4):487-9.
    View in: PubMed
    Score: 0.001
  40. Skillman TG, Falko JM. Recognizing thyroid disease in the elderly: current considerations. Geriatrics. 1981 Jan; 36(1):63-73.
    View in: PubMed
    Score: 0.001
  41. Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man. Clin Endocrinol (Oxf). 1980 Dec; 13(6):587-93.
    View in: PubMed
    Score: 0.001
  42. Falko JM. High density lipoprotein (HDL): a protective lipoprotein. Ohio State Med J. 1980 Aug; 76(8):513-5.
    View in: PubMed
    Score: 0.001
  43. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Salmon P. Effects of short-term high carbohydrate, fat-free diet on plasma levels of Apo C-II and Apo C-III and on the Apo C subspecies in human plasma lipoproteins. Metabolism. 1980 Jul; 29(7):654-61.
    View in: PubMed
    Score: 0.001
  44. Falko JM, Schonfeld G, Witztum JL, Kolar JB, Weidman SW, Steelman R. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins. J Clin Endocrinol Metab. 1980 Mar; 50(3):521-8.
    View in: PubMed
    Score: 0.001
  45. Falko JM, Schonfeld G, Witztum JL, Kolar J, Weidman SW. Effects of estrogen therapy on apolipoprotein E in type II hyperlipoproteinemia. Metabolism. 1979 Nov; 28(11):1171-7.
    View in: PubMed
    Score: 0.001
  46. Falko JM, Witztum JL, Schonfeld G, Bateman J. Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol. Ann Intern Med. 1979 Nov; 91(5):750-1.
    View in: PubMed
    Score: 0.001
  47. Falko JM, Williams JC, Harvey DG, Weidman SW, Schonfeld G, Dodson WE. Hyperlipoproteinemia and multifocal neurologic dysfunction in systemic lupus erythematosus. J Pediatr. 1979 Oct; 95(4):523-9.
    View in: PubMed
    Score: 0.001
  48. Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. Am J Med. 1979 Feb; 66(2):303-10.
    View in: PubMed
    Score: 0.001
  49. Sundaram V, Hanna AN, Lubow GP, Koneru L, Falko JM, Sharma HM. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci. 1997 Nov; 314(5):303-10.
    View in: PubMed
    Score: 0.001
  50. Thomas FB, Sinar D, Caldwell JH, Mekhjian HS, Falko JM. Stimulation of pancreatic secretion of water and electrolytes by furosemide. Gastroenterology. 1977 Aug; 73(2):221-5.
    View in: PubMed
    Score: 0.001
  51. Falko JM. Hazards in antihypertension therapy. Ann Intern Med. 1977 Jan; 86(1):111-2.
    View in: PubMed
    Score: 0.001
  52. Falko JM, Berenzweig HK. Letter: Thyrotoxic hypercalcemia, renal tubular acidosis, and pancreatitis. Ann Intern Med. 1976 Sep; 85(3):404.
    View in: PubMed
    Score: 0.001
  53. Falko JM, Guy JT, Smith RE, Mazzaferri EL. Primary hyperparathyroidism and anemia. Arch Intern Med. 1976 Aug; 136(8):887-9.
    View in: PubMed
    Score: 0.001
  54. Falko JM, Cohen JR. Letter: Erythrocytosis and hypothyroidism. Ann Intern Med. 1976 Apr; 84(4):446-7.
    View in: PubMed
    Score: 0.001
  55. Jhiang SM, Fithian L, Weghorst CM, Clark OH, Falko JM, O'Dorisio TM, Mazzaferri EL. RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid. 1996 Apr; 6(2):115-21.
    View in: PubMed
    Score: 0.001
  56. Falko JM, Bush CA, Tzagournis M, Thomas FB. Case report. Congestive heart failure complicating the hungry bone syndrome. Am J Med Sci. 1976 Jan-Feb; 271(1):85-9.
    View in: PubMed
    Score: 0.001
  57. Falko JM, Thomas FB. Letter: Acute pancreatitis due to procainamide-induced lupus erythematosus. Ann Intern Med. 1975 Dec; 83(6):832-3.
    View in: PubMed
    Score: 0.001
  58. Falko JM, Crockett SE, Cataland S, Mazzaferri EL. Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab. 1975 Aug; 41(2):260-5.
    View in: PubMed
    Score: 0.001
  59. Falko JM, Mekhjian HS, Thomas FB. Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstruction. Am J Dig Dis. 1975 Jun; 20(6):583-87.
    View in: PubMed
    Score: 0.001
  60. Olmos PR, Falko JM, Rea GL, Boesel CP, Chakeres DW, McGhee DB. Fibrosing pseudotumor of the sella and parasellar area producing hypopituitarism and multiple cranial nerve palsies. Neurosurgery. 1993 Jun; 32(6):1015-21; discussion 1021.
    View in: PubMed
    Score: 0.001
  61. Bello F, Falko JM, O'Dorisio TM, Osei K. The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patients. Diabet Med. 1991 May; 8(4):385-7.
    View in: PubMed
    Score: 0.001
  62. Osei K, Falko J, Bossetti BM, Holland GC. Metabolic effects of fructose as a natural sweetener in the physiologic meals of ambulatory obese patients with type II diabetes. Am J Med. 1987 Aug; 83(2):249-55.
    View in: PubMed
    Score: 0.000
  63. Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients. J Clin Endocrinol Metab. 1986 Feb; 62(2):325-30.
    View in: PubMed
    Score: 0.000
  64. Osei K, Falko JM, Fields PG, Bossetti B, O'Dorisio TM. The effects of carbohydrate-enriched meals on glucose turnover and metabolic clearance rates of glucose in type 2 diabetic patients. Diabetologia. 1986 Feb; 29(2):100-5.
    View in: PubMed
    Score: 0.000
  65. Pariser SF, Stern SL, Shank ML, Falko JM, O'Shaughnessy RW, Friedman CI. Premenstrual syndrome: concerns, controversies, and treatment. Am J Obstet Gynecol. 1985 Nov 15; 153(6):599-604.
    View in: PubMed
    Score: 0.000
  66. Abdel-Nabi H, Hinkle GH, Falko JM, Kelly D, Olsen JO, Martin EW. Iodine-131 labeled anti-CEA antibodies uptake by H?rthle cell carcinoma. Clin Nucl Med. 1985 Oct; 10(10):713-5.
    View in: PubMed
    Score: 0.000
  67. Osei K, Falko JM, O'Dorisio TM, Adam DR. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism. Diabetes Care. 1985 Sep-Oct; 8(5):436-9.
    View in: PubMed
    Score: 0.000
  68. Osei K, Falko JM, O'Dorisio TM, Adam DR, Cataland S. Significance of spontaneous ketonuria and serum C-peptide levels in obese type II diabetic patients. Diabetes Care. 1984 Sep-Oct; 7(5):442-6.
    View in: PubMed
    Score: 0.000
  69. Osei K, Falko JM, O'Dorisio TM, Adam DR. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care. 1984 Sep-Oct; 7(5):471-5.
    View in: PubMed
    Score: 0.000
  70. Abdel-Nabi H, Falko JM, Olsen JO, Freimanis AK. Solitary cold thyroid nodule: cost-ineffectiveness of ultrasonography. South Med J. 1984 Sep; 77(9):1146-8.
    View in: PubMed
    Score: 0.000
  71. Osei K, Falko JM, Nelson KP, Stephens R. Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med. 1984 Jul; 77(1):41-6.
    View in: PubMed
    Score: 0.000
  72. Levin P, Falko JM, O'Dorisio TM, Cataland S. Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabetics. Am J Med Sci. 1983 Nov-Dec; 286(3):11-7.
    View in: PubMed
    Score: 0.000
  73. Osei K, Falko JM, Pacht E, Wall R, Goldberg RF. Primary adrenal insufficiency manifesting as malignant lymphoma. Arch Intern Med. 1983 Sep; 143(9):1791-2.
    View in: PubMed
    Score: 0.000
  74. Pizzino J, Falko JM, Moses JL. Ocular changes in Graves' disease. Ohio State Med J. 1983 Aug; 79(8):627-9.
    View in: PubMed
    Score: 0.000
  75. Bissinger C, Falko JM, Maher W, Rarick M, Cerilli J, Johnson J. Hypertensive crisis induced by eating in a patient with pheochromocytoma. J Clin Gastroenterol. 1983 Apr; 5(2):155-7.
    View in: PubMed
    Score: 0.000
  76. Hill SA, Falko JM, Wilson CB, Hunt WE. Thyrotrophin-producing pituitary adenomas. J Neurosurg. 1982 Oct; 57(4):515-9.
    View in: PubMed
    Score: 0.000
  77. Friedman CI, Falko JM, Patel ST, Kim MH, Newman HA, Barrows H. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females. J Clin Endocrinol Metab. 1982 Aug; 55(2):258-62.
    View in: PubMed
    Score: 0.000
  78. Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. J Clin Endocrinol Metab. 1982 Jun; 54(6):1210-5.
    View in: PubMed
    Score: 0.000
  79. O'Dorisio TM, Falko JM, Cataland S, Almoney RW, George JM, Mazzaferri EL, Reynolds JC. Gastrin Responses to a test meal in patients with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 1982 Apr; 54(4):798-802.
    View in: PubMed
    Score: 0.000
  80. Schear EA, Falko JM, Cataland S, Johnson J, Fanning W. Diabetes insipidus and breast cancer. South Med J. 1982 Mar; 75(3):354-6.
    View in: PubMed
    Score: 0.000
  81. Abdel-Nabi H, Falko JM, Olsen J. The value of technetium Tc 99m pertechnetate thyroid scanning in the diagnosis of factitious thyrotoxicosis. Arch Intern Med. 1982 Mar; 142(3):644-5.
    View in: PubMed
    Score: 0.000
  82. Doherty DE, Falko JM, Lefkovitz N, Rogers J, Fromkes J. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP). Dig Dis Sci. 1982 Feb; 27(2):169-70.
    View in: PubMed
    Score: 0.000
  83. Abdel-Nabi H, Scheu J, Ragosin R, Falko JM, Olsen J. Thyroid uptake of Tc-99m compromising in vivo RBC tagging. J Nucl Med. 1981 Nov; 22(11):1018-9.
    View in: PubMed
    Score: 0.000
  84. Yovos JG, Falko JM, O'Dorisio TM, Malarkey WB, Cataland S, Capen CC. Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmos. J Clin Endocrinol Metab. 1981 Aug; 53(2):338-43.
    View in: PubMed
    Score: 0.000
  85. Pariser SF, Reynolds JC, Falko JM, Jones BA, Mencer DL. Arrhythmia induced by a tricyclic antidepressant in a patient with undiagnosed mitral valve prolapse. Am J Psychiatry. 1981 Apr; 138(4):522-3.
    View in: PubMed
    Score: 0.000
  86. Levin PA, Falko JM, Dixon K, Gallup EM, Saunders W. Benign parotid enlargement in bulimia. Ann Intern Med. 1980 Dec; 93(6):827-9.
    View in: PubMed
    Score: 0.000
  87. Weidman SW, Suarez B, Falko JM, Witztum JL, Kolar J, Raben M, Schonfeld G. Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. J Lab Clin Med. 1979 Apr; 93(4):549-69.
    View in: PubMed
    Score: 0.000
  88. Crockett SE, Cataland S, Falko JM, Mazzaferri EL. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects. J Clin Endocrinol Metab. 1976 Jun; 42(6):1098-103.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)